Epidemiology and mortality in dialysis patients with and without polycystic kidney disease: A national study in Taiwan

Journal of Nephrology

Volumn 26, Issue 4, 2013, Pages 755-762

  Lee, Pei Wen ^a   Chien, Chih Chiang ^b,c   Yang, Wu Chang ^a,d   Wang, Jhi Joung ^b   Lin, Chih Ching ^a,d  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

^c CHUNG HWA UNIVERSITY OF MEDICAL TECHNOLOGY   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

End stage renal disease; Mortality; Polycystic kidney disease; Risk factors; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEALTH INSURANCE; HEMODIALYSIS PATIENT; HUMAN; INCIDENCE; KIDNEY FAILURE; KIDNEY POLYCYSTIC DISEASE; LONGITUDINAL STUDY; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OVERALL SURVIVAL; POPULATION RESEARCH; PREDICTION; RISK ASSESSMENT; RISK FACTOR; SURVIVAL; SURVIVAL RATE; TAIWAN;

FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; POLYCYSTIC KIDNEY DISEASES; RENAL DIALYSIS; TAIWAN;

EID: 84880090306     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.5301/jn.5000224     Document Type: Article

References (26)

1. Torres VE, King BF, Chapman AB, et al. Consortium for Radio-logic Imaging Studies of Polycystic Kidney Disease (CRISP). Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2007;2(1):112-120.
2. King BF, Torres VE, Brummer ME, et al. Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP). Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney disease. Kidney Int. 2003;64(6):2214-2221.
3. Perrone RD, Ruthazer R, Terrin NC. Survival after end-stage renal disease in autosomal dominant polycystic kidney disease: contribution of extrarenal complications to mortality. Am J Kidney Dis. 2001;38(4):777-784.
4. Hwang SJ, Yang WC, Che HH. 1999 National Dialysis Surveillance in Taiwan. Acta Neurol (Napoli). 2000;14:139-228
5. Abbott KC, Agodoa LY. Polycystic kidney disease at end-stage renal disease in the United States: patient characteristics and survival. Clin Nephrol. 2002;57(3):208-214.
6. Hadimeri H, Nordén G, Friman S, Nyberg G. Autosomal dominant polycystic kidney disease in a kidney transplant population. Nephrol Dial Transplant. 1997;12(7):1431-1436.
7. Zeier M, Jones E, Ritz E. Autosomal dominant polycystic kidney disease: the patient on renal replacement therapy. Nephrol Dial Transplant. 1996;11(Suppl 6):18-20.
8. Patch C, Charlton J, Roderick PJ, Gulliford MC. Use of antihypertensive medications and mortality of patients with autosomal dominant polycystic kidney disease: a population-based study. Am J Kidney Dis. 2011;57(6):856-862.
9. Schrier RW, McFann KK, Johnson AM. Epidemiological study of kidney survival in autosomal dominant polycystic kidney disease. Kidney Int. 2003;63(2):678-685.
10. Chen HF, Chen P, Li CY. Risk of malignant neoplasms of liver and biliary tract in diabetic patients with different age and sex stratifications. Hepatology. 2010;52(1):155-163.
11. Chen HF, Ho CA, Li CY. Age and sex may significantly interact with diabetes on the risks of lower-extremity amputation and peripheral revascularization procedures: evidence from a cohort of a half-million diabetic patients. Diabetes Care. 2006;29(11):2409-2414.
12. Gonzalo A, Gallego A, Rivera M, Orte L, Ortuño J. Influence of hypertension on early renal insufficiency in autosomal dominant polycystic kidney disease. Nephron. 1996;72(2):225-230.
13. Bardají A, Martinez-Vea A, Valero A, et al. Cardiac involvement in autosomal-dominant polycystic kidney disease: a hypertensive heart disease. Clin Nephrol. 2001;56(3):211-220.
14. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int. 2002;62(5):1524-1538.
15. Ring T, Spiegelhalter D. Risk of intracranial aneurysm bleeding in autosomal-dominant polycystic kidney disease. Kidney Int. 2007;72(11):1400-1402.
16. Gabow PA, Chapman AB, Johnson AM, et al. Renal structure and hypertension in autosomal dominant polycystic kidney disease. Kidney Int. 1990;38(6):1177-1180.
17. Barrett BJ, Foley R, Morgan J, Hefferton D, Parfrey P. Differences in hormonal and renal vascular responses between normotensive patients with autosomal dominant polycystic kidney disease and unaffected family members. Kidney Int. 1994;46(4):1118-1123.
18. Ecder T, Schrier RW. Hypertension in autosomal-dominant polycystic kidney disease: early occurrence and unique aspects. J Am Soc Nephrol. 2001;12(1):194-200.
19. Schievink WI, Torres VE, Piepgras DG, Wiebers DO. Saccular intracranial aneurysms in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 1992;3(1):88-95.
20. Yang WC, Hwang SJ. Taiwan Society of Nephrology. Incidence, prevalence and mortality trends of dialysis endstage renal disease in Taiwan from 1990 to 2001: the impact of national health insurance. Nephrol Dial Transplant. 2008;23(12):3977-3982.
21. Schroijen MA, Dekkers OM, Grootendorst DC, et al. NECOSAD Study Group. Survival in dialysis patients is not different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition. BMC Nephrol. 2011;12(1):69.
22. Rodríguéz JA, Clèries M, Vela E. Registry Committee R; Renal Registry Committee. Diabetic patients on renal replacement therapy: analysis of Catalan Registry data. Nephrol Dial Transplant. 1997;12(12):2501-2509.
23. Collins AJ, Foley RN, Herzog C, et al. US Renal Data System 2010 annual data report. Am J Kidney Dis. 2011; 57(1) (A8):e1-e526.
24. Wakai K, Nakai S, Kikuchi K, et al. Trends in incidence of end-stage renal disease in Japan, 1983-2000: age-adjusted and age-specific rates by gender and cause. Nephrol Dial Transplant. 2004;19(8):2044-2052.
25. Glass RB, Astrin KH, Norton KI, et al. Fabry disease: renal sonographic and magnetic resonance imaging findings in affected males and carrier females with the classic and cardiac variant phenotypes. J Comput Assist Tomogr. 2004;28(2):158-168.
26. Pisani A, Riccio E, Cianciaruso B, Imbriaco M. Simultaneous multicystic kidney and Anderson-Fabry disease: 2 separate entities or same side of the coin. J Nephrol. 2011;24(6): 806-808.